Peter Ginsberg

Peter Ginsberg is currently the EVP of Corporate Development at Foundation Fighting Blindness. Prior to this, they were with Savara Inc. from January 2018 to November 2020 as the Vice President of Business Development. Ginsberg then moved on to United Therapeutics Corporation from March 2015 to October 2016 as the Associate Vice President of Business Development. During their time at United Therapeutics, they were promoted to Senior Director after their first year and successfully completed the sale of a Priority Review Voucher for a record $350 million. From 2010 to 2015, Ginsberg was with NCBiotech as the Vice President of Business & Technology Development. In this role, they led a group that acted as a hub for healthcare industry activity in North Carolina. This included investments, partnerships, and relationships with rare disease foundations and NORD. Under their leadership, the SE Venture Philanthropy Summit attracted 30+ foundations and 300 participants.

Peter Ginsberg attended Princeton University as an undergrad, where they studied Economics. Peter then went on to get their MBA from the Tuck School of Business at Dartmouth. Peter is also a Chartered Financial Analyst (CFA) and has a certification from the Bell Leadership Institute in Bell Leadership Institute: Achievers.

Peter Ginsberg works with Jason Menzo - President & COO, Claire M. Gelfman - Chief Scientific Officer, and Amy Laster - VP, Science & Awards Programs. Peter Ginsberg reports to Benjamin R. Yerxa, CEO.